Antonio Boccia

523 total citations
4 papers, 304 citations indexed

About

Antonio Boccia is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Antonio Boccia has authored 4 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 1 paper in Pathology and Forensic Medicine and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Antonio Boccia's work include Melanoma and MAPK Pathways (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Growth Hormone and Insulin-like Growth Factors (1 paper). Antonio Boccia is often cited by papers focused on Melanoma and MAPK Pathways (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Growth Hormone and Insulin-like Growth Factors (1 paper). Antonio Boccia collaborates with scholars based in United States. Antonio Boccia's co-authors include Rui L. Zhang, Brian P. Eliceiri, Robert Paul, Michael Chopp, Quan Jiang, Zheng G. Zhang, David A. Cheresh, Ingrid B.J. Joseph, Peter Chu and Jianying Dong and has published in prestigious journals such as Nature Medicine, Journal of Interferon & Cytokine Research and European Journal of Cancer Supplements.

In The Last Decade

Antonio Boccia

4 papers receiving 297 citations

Peers

Antonio Boccia
Comparison fields: 5 of 56
  • Molecular Biology 187
  • Neurology 68
  • Cellular and Molecular Neuroscience 48
  • Cancer Research 42
  • Cell Biology 36
Replace Zhongmin Yuan with:
Zhongmin Yuan China
Hengrui Sun United States
Tomoya Adachi Japan
Pontus Larsson Sweden
Karolina Dzwonek Poland
Jingshu Tang China
Zhongping Liao United States
Anne‐Lise Glotin France
Nina Ha South Korea
Yuki Toda Japan
Zhongmin Yuan China View profile →
Citations per field, relative to Antonio Boccia
Antonio Boccia · 1×
Citations per year, relative to Antonio Boccia
Antonio Boccia · 1×

Countries citing papers authored by Antonio Boccia

Since Specialization
Citations

This map shows the geographic impact of Antonio Boccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Boccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Boccia more than expected).

Fields of papers citing papers by Antonio Boccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Boccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Boccia. The network helps show where Antonio Boccia may publish in the future.

Co-authorship network of co-authors of Antonio Boccia

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Boccia. A scholar is included among the top collaborators of Antonio Boccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Boccia. Antonio Boccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
# Work Indexed citations
1 4
2 4
3
BIIB022, a human antibody targeting human insulin-like growth factor-1 receptor (IGF-1R), enhances the anti-tumor activities of Tarceva in non-small cell lung carcinoma (NSCLC) and Rapamycin in sarcoma cell lines
7
4 289

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026